<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2023_1_17</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-113</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Отношение нейтрофилов к лимфоцитам у больных с циррозом печени в зависимости от исхода госпитализации</article-title><trans-title-group xml:lang="en"><trans-title>Neutrophil-to-lymphocyte ratio in patients with liver cirrhosis depending on the outcome of hospitalization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Davydova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>664003; ул. Красного Восстания, 1; Иркутск</p></bio><bio xml:lang="en"><p>664003; 1 Krasnogo Vosstaniya street; Irkutsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дульский</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dul'skiy</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>664003; ул. Красного Восстания, 1; Иркутск</p></bio><bio xml:lang="en"><p>664003; 1 Krasnogo Vosstaniya street; Irkutsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Иркутский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>08</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>17</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Давыдова А.В., Дульский В.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Давыдова А.В., Дульский В.А.</copyright-holder><copyright-holder xml:lang="en">Davydova A.V., Dul'skiy V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/113">https://www.zabmedvestnik.ru/jour/article/view/113</self-uri><abstract><sec><title>   Цель исследования</title><p>   Цель исследования. Оценить функциональное состояние печени, индексы MELD, Чайлд-Пью, индекс отношения нейтрофилов к лимфоцитам (ОНЛ) у больных циррозом печени в зависимости от исхода госпитализации; применить показатель ОНЛ в собственной клинической практике.</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы. Обследованы 69 пациентов с диагнозом «Цирроз печени». Проведено стандартное обследование (общий и биохимический анализ крови, УЗИ, ФГДС), рассчитаны индексы Child-Pugh и MELD, индекс ОНЛ (путём деления абсолютного числа нейтрофилов на абсолютное число лимфоцитов) у каждого пациента.</p></sec><sec><title>   Результаты</title><p>   Результаты. Пациенты были разделены на две группы в зависимости от исхода госпитализации: выжившие (47/68 %) и умершие (22/32 %). Группы не различались по полу и возрасту, по степени выраженности портальной гипертензии. В группе умерших закономерно отмечались более высокие индексы Child-Pugh [13 (12-13) vs 10 (8-11); р &lt; 0,0001] и MELD [28 (25-34,5) vs 13 (9-18); р &lt; 0,0001]. Индекс ОНЛ был также значимо выше в группе умерших больных циррозом печени: 12,8 (5,7-18,7) vs 2,6 (1,8-3,8) (р &lt; 0,0001). Низкий ОНЛ (менее 1) одинаково часто встречался в группах выживших и умерших больных: 8,5 % vs 4,6 % (р = 0,55); от 1 до 6 чаще имел место в группе выживших: 80,9 % vs 22,7 % (р &lt; 0,0001); более 6 – значимо чаще встречался в группе умерших больных: 72,7 % vs 10,6 % (р &lt; 0,0001). Обнаружена положительная статистически значимая средней силы корреляционная связь между индексом ОНЛ и СРБ (ρ = 0,67; p &lt; 0,05), ОНЛ и MELD (ρ = 0,52; p &lt; 0,05).</p></sec><sec><title>   Заключение</title><p>   Заключение. Таким образом, ОНЛ показал себя хорошим и доступным индикатором риска летального исхода заболевания у пациентов с декомпенсированным циррозом печени в текущую госпитализацию. ОНЛ более 6 может использоваться в широкой клинической практике как предиктор неблагоприятного исхода в текущую госпитализацию у больных с циррозом печени.</p></sec></abstract><trans-abstract xml:lang="en"><p>     The aim of the research. Assess the functional state of the liver, MELD and Child-Pugh indices, neutrophil-to-lymphocyte ratio (NLR) in patients with liver cirrhosis, depending on the outcome of hospitalization; apply the NLR indicator in one’s own clinical practice.</p><sec><title>   Materials and methods</title><p>   Materials and methods. 69 patients diagnosed with liver cirrhosis were examined. A standard examination was performed (CBC and biochemical blood tests, ultrasound, upper endoscopy), Child-Pugh and MELD indices, NLR index (by dividing the absolute number of neutrophils by the absolute number of lymphocytes) were calculated for each patient.</p></sec><sec><title>   Results</title><p>   Results. Patients were divided into two groups depending on the outcome of hospitalization: survivors (47/68 %) and dead (22/32 %). The groups did not differ in sex and age, in the portal hypertension severity. Among dead patients higher Child-Pugh [13 (12-13) vs 10 (8-11); p &lt; 0.0001] and MELD indices [28 (25-34.5) vs 13 (9-18); p &lt; 0.0001] were naturally observed. The NLR index was also significantly higher among dead patients with liver cirrhosis: 12.8 (5.7-18.7) vs 2.6 (1.8-3.8) (p &lt; 0.0001). Low NLR (less than 1) was equally common in both groups: 8.5 % vs 4.6 % (p = 0.55); from 1 to 6 more often occurred in the group of survivors: 80.9 % vs 22.7 % (p &lt; 0.0001); more than 6 - significantly more common in the group of dead patients: 72.7 % vs 10.6 % (p &lt; 0.0001). A positive statistically significant correlation was found between the NLR index and CRP (ρ = 0.67; p &lt; 0.05), NLR and MELD (ρ = 0.52; p &lt; 0.05).</p></sec><sec><title>   Conclusion</title><p>   Conclusion. Thus, NLR proved to be a good and accessible indicator of the risk of a lethal outcome among patients with decompensated liver cirrhosis during the current hospitalization. NLR more than 6 can be used in wide clinical practice as a predictor of adverse outcome in the current hospitalization in patients with liver cirrhosis.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>цирроз печени</kwd><kwd>отношение нейтрофилов к лимфоцитам</kwd><kwd>исходы госпитализации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>liver cirrhosis</kwd><kwd>neutrophil-to-lymphocyte ratio</kwd><kwd>outcomes of hospitalization</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование никем не финансировалось</funding-statement><funding-statement xml:lang="en">The study was not funded by anyone</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Маевская М.В., Жаркова М.С., Жигалова С.Б., Киценко Е.А., Манукьян Г.В., Трухманов А.С., Маев И.В., Тихонов И.Н., Деева Т.А. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по диагностике и лечению фиброза и цирроза печени и их осложнений. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021. 31(6). 56-102. URL: https://www.gastro-j.ru/jour/article/view/621?locale=ru_RU</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Maevskaya M.V., Zharkova M.S., Zhigalova S.B., Kitsenko E.A., Manukyan G.V., Trukhmanov A.S., Maev I.V., Tikhonov I.N., Deeva T.A. Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Complications. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021. 31(6). 56-102. URL: https://www.gastro-j.ru/jour/article/view/621?locale=ru_RU. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Масленников Р.В., Дрига А.А., Ивашкин К.В., Жаркова М.С., Маевская М.В., Павлов Ч.С., Арсланян М.Г., Мусина Н.Б., Березина Е.Н., Ивашкин В.Т. Роль синдрома избыточного бактериального роста и системного воспаления в патогенезе гемодинамических изменений у больных циррозом печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017. 27(3). 45-56. URL: https://www.gastro-j.ru/jour/article/view/157</mixed-citation><mixed-citation xml:lang="en">Maslennikov R.V., Driga A.A., Ivashkin K.V., Zharkova M.S., Mayevskaya M.V., Pavlov C.S., Arslanyan M.G., Musina N.B., Berezina Y.N., Ivashkin V.T. Small intestinal bacterial overgrowth syndrome and systemic inflammation in pathogenesis of hemodynamic changes at liver cirrhosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017. 27(3)/45-56. URL: https://www.gastro-j.ru/jour/article/view/157. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dirchwolf M., Ruf A.E. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World J Hepatol. 2015. 7(16). 1974-81. doi: 10.4254/wjh.v7.i16.1974.</mixed-citation><mixed-citation xml:lang="en">Dirchwolf M., Ruf A.E. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World J Hepatol. 2015. 7(16). 1974-81. doi: 10.4254/wjh.v7.i16.1974.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Folden A. Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for the liver transplantation in 1999 and 2004. Transplant Proc 2007. 39. 385-386. doi: 10.1016/j.transproceed.2007.01.013.</mixed-citation><mixed-citation xml:lang="en">Folden A. Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for the liver transplantation in 1999 and 2004. Transplant Proc 2007. 39. 385-386. doi: 10.1016/j.transproceed.2007.01.013.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Russell C.D., Parajuli A., Gale H.J.,et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases : A systematic review and meta-analysis. J Infect. 2019 May. 78(5). 339-348. doi: 10.1016/j.jinf.2019.02.006.</mixed-citation><mixed-citation xml:lang="en">Russell C.D., Parajuli A., Gale H.J.,et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases : A systematic review and meta-analysis. J Infect. 2019 May. 78(5). 339-348. doi: 10.1016/j.jinf.2019.02.006.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Absenger G., Szkandera J., Pichler M. et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. British Journal of Cancer. 2013. 109(2). 395–400. doi: 10.1038/bjc.2013.346.</mixed-citation><mixed-citation xml:lang="en">Absenger G., Szkandera J., Pichler M. et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. British Journal of Cancer. 2013. 109(2). 395-400. doi: 10.1038/bjc.2013.346.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gemenetzis G., Bagante F., Griffin J.F., et al. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2017 Aug. 266(2). 339-345. URL: https://typeset.io/papers/neutrophil-to-lymphocyte-ratio-is-a-predictive-marker-for-5e4gldcefa.</mixed-citation><mixed-citation xml:lang="en">Gemenetzis G., Bagante F., Griffin J.F., et al. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2017 Aug. 266(2). 339-345. URL: https://typeset.io/papers/neutrophil-to-lymphocyte-ratio-is-a-predictive-marker-for-5e4gldcefa.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shi M., Zhao W., Zhou F., et al. Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma. Transl Lung Cancer Res. 2020 Feb. 9(1). 45-54. doi: 10.21037/tlcr.2020.01.17.</mixed-citation><mixed-citation xml:lang="en">Shi M., Zhao W., Zhou F., et al. Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma. Transl Lung Cancer Res. 2020 Feb. 9(1). 45-54. doi: 10.21037/tlcr.2020.01.17.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bhat T., Teli S., Rijal J. et al. Neutrophil to lymphocyte ratio and cardiovascular diseases : a review. Expert Review of Cardiovascular Therapy. 2013. 11(1). 55-9. doi: 10.1586/erc.12.159.</mixed-citation><mixed-citation xml:lang="en">Bhat T., Teli S., Rijal J. et al. Neutrophil to lymphocyte ratio and cardiovascular diseases : a review. Expert Review of Cardiovascular Therapy. 2013. 11(1). 55-9. doi: 10.1586/erc.12.159.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chen L., Lou Y., Chen Y., Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. International Journal of Clinical Practice. 2014. 68(8). 1034-40. doi: 10.1111/ijcp.12408.</mixed-citation><mixed-citation xml:lang="en">Chen L., Lou Y., Chen Y., Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. International Journal of Clinical Practice. 2014. 68(8). 1034-40. doi: 10.1111/ijcp.12408.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lin L., Yang F., Wang Y. et al. Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis. Int Immunopharmacol. 2018. 56(3). 58-64. doi: 10.1016/j.intimp.2018.01.007.</mixed-citation><mixed-citation xml:lang="en">Lin L., Yang F., Wang Y. et al. Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis. Int Immunopharmacol. 2018. 56(3). 58-64. doi: 10.1016/j.intimp.2018.01.007.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang S.Y., Shin T.G., Jo I.J., et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017 Feb. 35(2). 234-239. doi: 10.1016/j.ajem.2016.10.055.</mixed-citation><mixed-citation xml:lang="en">Hwang S.Y., Shin T.G., Jo I.J., et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017 Feb. 35(2). 234-239. doi: 10.1016/j.ajem.2016.10.055.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wu X, Luo Q, Su Z, et al. Neutrophil-to-lymphocyte ratio as a predictor of mortality in intensive care unit patients: a retrospective analysis of the Medical Information Mart for Intensive Care III Database. BMJ Open 2021. 11. e053548. doi: 10.1136/bmjopen-2021-053548.</mixed-citation><mixed-citation xml:lang="en">Wu X, Luo Q, Su Z, et al. Neutrophil-to-lymphocyte ratio as a predictor of mortality in intensive care unit patients: a retrospective analysis of the Medical Information Mart for Intensive Care III Database. BMJ Open 2021. 11. e053548. doi: 10.1136/bmjopen-2021-053548.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Луньков В.Д., Маевская М.В., Цветаева Е.К., и др. Отношение нейтрофилов к лимфоцитам как предиктор неблагоприятного исхода у пациентов с декомпенсированным циррозом печени. Росс. журн. гастроэнтерол. гепатол. колопроктол. 2019. 29(1). 47-61. doi: 10.22416/1382-4376-2019-29-1-47-61.</mixed-citation><mixed-citation xml:lang="en">Lunkov V.D., Maevskaya M.V., Tsvetaeva E.K., Mendez A.G., Zharkova M.S., Tkachenko P.E., Ivashkin V.T. Neutrophil to Lymphocyte Ratio as a Predictor of Adverse Outcome in Patients with Decompensated Liver Cirrhosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019. 29(1). 47-61. doi: 10.22416/1382-4376-2019-29-1-47-61. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kamath P.S., Wiesner R.H., Malinchoc M. A model to predict survival in patients with end-stage liver disease. Hepatology 2001. 33(2). 464-470. doi: 10.1053/jhep.2001.22172.</mixed-citation><mixed-citation xml:lang="en">Kamath P.S., Wiesner R.H., Malinchoc M. A model to predict survival in patients with end-stage liver disease. Hepatology 2001. 33(2). 464-470. doi: 10.1053/jhep.2001.22172.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
